The MHRA has reviewed the warnings regarding addiction, dependence, withdrawal, and
tolerance for gabapentin, pregabalin, benzodiazepines, and z-drugs. The findings (detailed in the Public Assessment Report) were that it wa…
This content is sourced from MHRA and reproduced for clinical reference. ClinicalIQ does not alter source content.